Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elegancia Group is a Qatari conglomerate with major activities in services, industries, contracting/construction, and healthcare. Its healthcare division was rebranded as Apex Health in 2024 and manages hospitals across Qatar, Algeria, Iraq and other regions. The group was acquired by Investment Holding Group (now Estithmar Holding) in April 2022. There are no clinical trial results or therapeutic pipelines typical of biopharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elegancia Group.